Unknown

Dataset Information

0

Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.


ABSTRACT: Importance:An elevated level of urinary albumin to creatinine ratio (UACR) is a marker of renal dysfunction and predictor of kidney failure/death in patients with type 2 diabetes. The prognostic use of UACR in established cardiac biomarkers is not well described. Objective:To evaluate whether UACR offers incremental prognostic benefit beyond risk factors and established plasma cardiovascular biomarkers. Design, Setting, and Participants:The Saxagliptin Assessment of Vascular Outcomes Recorded in Patients With Diabetes Mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 study was performed from May 2010 to May 2013 and evaluated the safety of saxagliptin vs placebo in patients with type 2 diabetes with overt cardiovascular disease or multiple risk factors. Median follow-up was 2.1 years (interquartile range, 1.8-2.3 years). Interventions:Patients were randomized to saxagliptin vs placebo plus standard care. Main Outcomes and Measures:Baseline UACR was measured in 15?760 patients (95.6% of the trial population) and categorized into thresholds. Results:Of 15?760 patients, 5205 were female (33.0%). The distribution of UARC categories were: 5805 patients (36.8%) less than 10 mg/g, 3891 patients (24.7%) at 10 to 30 mg/g, 4426 patients (28.1%) at 30 to 300 mg/g, and 1638 patients (10.4%) at more than 300 mg/g. When evaluated without cardiac biomarkers, there was a stepwise increase with each higher UACR category in the incidence of the primary composite end point (cardiovascular death, myocardial infarction, or ischemic stroke) (3.9%, 6.9%, 9.2%, and 14.3%); cardiovascular death (1.4%, 2.6%, 4.1%, and 6.9%); and hospitalization for heart failure (1.5%, 2.5%, 4.0%, and 8.3%) (adjusted P?

SUBMITTER: Scirica BM 

PROVIDER: S-EPMC6594440 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Scirica Benjamin M BM   Mosenzon Ofri O   Bhatt Deepak L DL   Udell Jacob A JA   Steg Ph Gabriel PG   McGuire Darren K DK   Im KyungAh K   Kanevsky Estella E   Stahre Christina C   Sjöstrand Mikaela M   Raz Itamar I   Braunwald Eugene E  

JAMA cardiology 20180201 2


<h4>Importance</h4>An elevated level of urinary albumin to creatinine ratio (UACR) is a marker of renal dysfunction and predictor of kidney failure/death in patients with type 2 diabetes. The prognostic use of UACR in established cardiac biomarkers is not well described.<h4>Objective</h4>To evaluate whether UACR offers incremental prognostic benefit beyond risk factors and established plasma cardiovascular biomarkers.<h4>Design, setting, and participants</h4>The Saxagliptin Assessment of Vascula  ...[more]

Similar Datasets

| S-EPMC3458466 | biostudies-literature
| S-EPMC6181277 | biostudies-literature
| S-EPMC9396793 | biostudies-literature
| S-EPMC8032218 | biostudies-literature
| S-EPMC8604302 | biostudies-literature
| S-EPMC8011002 | biostudies-literature
| S-EPMC6712860 | biostudies-other
| S-EPMC4974894 | biostudies-literature
| S-EPMC2723977 | biostudies-literature
| S-EPMC8032014 | biostudies-literature